42 USC 247 - Prenatal and postnatal health

Editorial Notes

Amendments

2018—Subsec. (a)(1). Puspan. L. 115–271, § 7064(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “to collect, analyze, and make available data on prenatal smoking, alcohol and illegal drug use, including data on the implications of such activities and on the incidence and prevalence of such activities and their implications;”.

Subsec. (a)(2). Puspan. L. 115–271, § 7064(1)(B), substituted “prevention and long-term outcomes associated with” for “prevention of” and “other substance abuse and misuse” for “illegal drug use”.

Subsec. (a)(3). Puspan. L. 115–271, § 7064(1)(C), substituted “, treatment, and cessation programs;” for “and cessation programs; and”.

Subsec. (a)(4). Puspan. L. 115–271, § 7064(1)(D), substituted “other substance abuse and misuse; and” for “illegal drug use.”.

Subsec. (a)(5). Puspan. L. 115–271, § 7064(1)(E), added par. (5).

Subsec. (span). Puspan. L. 115–271, § 7064(2), inserted “tribal entities,” after “local governments,”.

Subsec. (c). Puspan. L. 115–271, § 7064(4), added subsec. (c). Former subsec. (c) redesignated (d).

Subsec. (d). Puspan. L. 115–271, § 7064(3), (5), redesignated subsec. (c) as (d) and substituted “2019 through 2023” for “2001 through 2005”.

Statutory Notes and Related Subsidiaries

Improving Data and the Public Health Response

Puspan. L. 114–91, § 4, Nov. 25, 2015, 129 Stat. 725, provided that: “The Secretary [of Health and Human Services] may continue activities, as appropriate, related to—

“(1) providing technical assistance to support States and Federally recognized Indian Tribes in collecting information on neonatal abstinence syndrome through the utilization of existing surveillance systems and collaborating with States and Federally recognized Indian Tribes to improve the quality, consistency, and collection of such data; and

“(2) providing technical assistance to support States in implementing effective public health measures, such as disseminating information to educate the public, health care providers, and other stakeholders on prenatal opioid use and neonatal abstinence syndrome.”